Mankind Pharma Ltd. (MANKIND)
BSE
Real-time Data
03:45 AM
Day's Range
2,368.0052 wk Range
1,909.90Overview - MANKIND - Mankind Pharma Ltd.
Key Statistics
Valuation
Enterprise Value
1.02T
P/E (Trailing)
‪48.13‬
P/E (Forward)
‪33.68‬
PEG Ratio
‪1.37‬
Price / Sales (TTM)
‪6.65‬
Price / Book
‪6.01‬
EV / EBITDA
‪26.33‬
Profitability
Gross Margin
‪72.75%‬
Profit Margin
‪13.85%‬
Operating Margin
‪20.60%‬
Return on Assets
‪6.81%‬
Return on Equity
‪11.55%‬
Ownership
Shares Outstanding
412.99M
Float
112.94M
Held by Insiders
‪75.40%‬
Held by Institutions
‪19.51%‬
Price stats
Beta
‪0.46‬
50-Day Avg
‪2,480.96‬
200-Day Avg
‪2,271.55‬
Dividends
Payout Ratio
‪2.02%‬
Analyst Consensus
19 analysts
Market Cap - MANKIND - Mankind Pharma Ltd.
Peers - MANKIND - Mankind Pharma Ltd.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on BSE.
- MANKINDBSEMankind Pharma Ltd.999.45BMarket Cap-2.06%52-week change48.89P/E (Trailing)‪13.85%‬Profit Margin
- DIVISLABBSEDivi's Laboratories Ltd.2.25TMarket Cap+27.45%52-week change87.72P/E (Trailing)‪26.04%‬Profit Margin
- CIPLABSECipla Ltd.1.14TMarket Cap-11.64%52-week change25.39P/E (Trailing)‪16.25%‬Profit Margin
- LAURUSLABSBSELaurus Labs Ltd.1.00TMarket Cap+54.36%52-week change89.19P/E (Trailing)‪15.04%‬Profit Margin
- LUPINBSELupin Ltd.1.00TMarket Cap+10.42%52-week change23.24P/E (Trailing)‪17.47%‬Profit Margin
- DRREDDYBSEDr. Reddy's Laboratories Ltd.994.50BMarket Cap-6.92%52-week change17.61P/E (Trailing)‪16.36%‬Profit Margin
- AUROPHARMABSEAurobindo Pharma Ltd.936.28BMarket Cap+35.16%52-week change27.51P/E (Trailing)‪10.52%‬Profit Margin
Profile Summary - MANKIND - Mankind Pharma Ltd.
About
Mankind Pharma Ltd. is a prominent pharmaceutical company based in India, focusing on the development, manufacturing, and marketing of a diverse range of pharmaceutical products. The company is recognized for its extensive portfolio that includes prescription medications, over-the-counter products, and a variety of…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
